Download PDF
CC BY-NC-ND 4.0 · Sleep Sci 2017; 10(02): 64-67
DOI: 10.5935/1984-0063.20170011
OVERVIEWS

Electrolyte imbalance and sleep problems during anti-retroviral therapy: an under-recognized problem

Md Dilshad Manzar
1   Department of Biomedical Sciences, College of Health Sciences, Mizan-Tepi University (Mizan Campus), ETHIOPIA Mizan-Aman - Etiópia
,
Peter Sony
1   Department of Biomedical Sciences, College of Health Sciences, Mizan-Tepi University (Mizan Campus), ETHIOPIA Mizan-Aman - Etiópia
,
Mohammed Salahuddin
1   Department of Biomedical Sciences, College of Health Sciences, Mizan-Tepi University (Mizan Campus), ETHIOPIA Mizan-Aman - Etiópia
,
Abera Kumalo
1   Department of Biomedical Sciences, College of Health Sciences, Mizan-Tepi University (Mizan Campus), ETHIOPIA Mizan-Aman - Etiópia
,
Mathewos Geneto
1   Department of Biomedical Sciences, College of Health Sciences, Mizan-Tepi University (Mizan Campus), ETHIOPIA Mizan-Aman - Etiópia
,
Seithikurippu R Pandi-Perumal
2   Somnogen Canada Inc, College Street, ON, Canada - Toronto - Ontario - Canadá
,
Adam Moscovitch
5   The University of Calgary, Sleep and Fatigue Institute - Calgary - Alberta - Canadá
,
Ahmed S BaHammam
3   College of Medicine, King Saud University, The University Sleep Disorders Center - Riyadh - Riyadh - Arábia Saudita
4   King Saud Univeristy, National Plan for Science and Technology - Riyadh - Riyadh - Arábia Saudita
› Author Affiliations
› Further Information
   Permissions and Reprints

Human immunodeficiency virus (HIV) infection, and the anti-retroviral therapy (ART) associated complications necessitate that the medical care system keeps evolving for proper management of this group of patients. Electrolyte imbalance and sleep problems are common in patients on ART. Both of these conditions are associated with increased morbidity (such as acute kidney injury, chronic kidney disease, low CD4 count, non-adherence and depression) and mortality. Therefore, screening for both sleep problems and electrolytes imbalance may help to decrease the risk of complications in patients on ART.

Mortality - Water-Electrolyte Imbalance - Anti-Retroviral Agents - AIDS Serodiagnosis

Funding Statement

No funding has been reported for this study.


Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.


Informed consent

Not applicable for this study.




Publication History

Received: 30 March 2017

Accepted: 12 May 2017

Article published online:
09 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • 1 The Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS Update 2016 [cited 2017 Jun 5]. Available from: http://www.unaids.org/ sites/default/files/media_asset/global-AIDS-update-2016_en.pdf
  • 2 Yaya I, Landoh DE, Saka B, Patchali PM, Wasswa P, Aboubakari AS, et al. Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo. BMC Public Health. 2014;14:1308.
  • 3 Heimburger DC, Koethe JR, Nyirenda C, Bosire C, Chiasera JM, Blevins M, et al. Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study. PLoS One. 2010;5(5):e10687.
  • 4 Santos MS, Seguro AC, Andrade L. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. Braz J Med Biol Res. 2010;43(3):316-23.
  • 5 Dao CN, Peters PJ, Kiarie JN, Zulu I, Muiruri P, Ong’ech J, et al. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retroviruses. 2011;27(11):1149-55.
  • 6 Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011;25(9):517-24.
  • 7 Seay JS, McIntosh R, Fekete EM, Fletcher MA, Kumar M, Schneiderman N, et al. Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV. Psychoneuroendocrinology. 2013;38(11):2647-53.
  • 8 Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep. 2002;51(RR-7):1-55.
  • 9 Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, Shaukat M, et al. Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India. PLoS One. 2013;8(6):e66860.
  • 10 Patil SP, Brown TT, Jacobson LP, Margolick JB, Laffan A, Johnson-Hill L, et al. Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and -uninfected men. PLoS One. 2014;9(7):e99258.
  • 11 Ortiz-Interian CJ, de Medina MD, Perez GO, Bourgoignie JJ, Watkins F, Velez-Robinson E, et al. Recurrence and clearance of hepatitis B surface antigenemia in a dialysis patient infected with the human immunodeficiency virus. Am J Kidney Dis. 1990;16(2):154-6.
  • 12 Salifu MO, Misra N. HIV-Associated Nephropathy. MedScape; 2015. p. [cited 2017 Jun 2]. Available from: http://emedicine.medscape.com/ article/246031-overview#showall
  • 13 Kalyesubula R, Perazella M. HIV-related drug nephrotoxicity In subsaharan Africa. Internet J Nephrol. 2009;6(1):1-10.
  • 14 Lo Re V 3rd, Schutte-Rodin S, Kostman JR. Obstructive sleep apnoea among HIV patients. Int J STD AIDS. 2006;17(9):614-20.
  • 15 Taibi DM. Sleep disturbances in persons living with HIV. J Assoc Nurses AIDS Care. 2013;24(1 Suppl):S72-85.
  • 16 Cruess DG, Antoni MH, Gonzalez J, Fletcher MA, Klimas N, Duran R, et al. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res. 2003;54(3):185-9.
  • 17 Crum-Cianflone NF, Roediger MP, Moore DJ, Hale B, Weintrob A, Ganesan A, et al. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012;54(10):1485-94.
  • 18 Ejeliogu EU, Ebonyi AO, Okpe SE, Yiltok ES, Ige OO, Ochoga MO, et al. Pattern of Adverse Drug Reaction in HIV-infected Children onAnti- Retroviral Therapy in Jos, Nigeria. Open Sci J Clin Med. 2014;2(4):89-93.
  • 19 Elder SJ, Pisoni RL, Akizawa T, Fissell R, Andreucci VE, Fukuhara S, et al Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23(3):998-1004.
  • 20 Iliescu EA, Yeates KE, Holland DC. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant. 2004;19(1):95-9.
  • 21 Phillips KD, Moneyham L, Murdaugh C, Boyd MR, Tavakoli A, Jackson K, et al. Sleep disturbance and depression as barriers to adherence. Clin Nurs Res. 2005;14(3):273-93.